Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 938 clinical trials in Leiden, The Netherlands across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
The NetherlandsStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
The NetherlandsStudy of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer
The NetherlandsStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
The NetherlandsStudy Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma
The NetherlandsStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
The NetherlandsStudy on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia
The NetherlandsStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
The NetherlandsStudy on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis
The NetherlandsStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
The NetherlandsLong-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa
The NetherlandsStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on viral infections including trials evaluating vaccines against yellow fever, influenza, and mpox. Research includes assessment of antibody responses and vaccine effectiveness in different populations.
Particular emphasis on preventive strategies and immune response evaluation.
Comprehensive research targeting neurological conditions, including investigations into Parkinson's disease treatments and neural response patterns. Studies examine innovative therapeutic approaches.
Focus on developing targeted therapies and understanding brain mechanisms.
Advanced research in oncology and chronic diseases, including studies on gastric cancer imaging and T-cell lymphoma treatments. Investigations into kidney disease management.
Emphasis on innovative diagnostic techniques and treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
